252 related articles for article (PubMed ID: 32681658)
21. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
22. Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy.
Pan T; Qi J; You T; Han S; Yang L; Miao W; Wu D; Ruan C; Zhu L; Han Y
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1486-1491. PubMed ID: 30871975
[TBL] [Abstract][Full Text] [Related]
23. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
[TBL] [Abstract][Full Text] [Related]
24. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
25. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
26. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
27. Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.
Ardissino G; Salardi S; Berra S; Colussi G; Cugno M; Zecca M; Giglio F; Peccatori J; Diral E; Tel F; Clivio A; Tedeschi S
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1580-1582. PubMed ID: 28522344
[TBL] [Abstract][Full Text] [Related]
28. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and Therapy.
Saab KR; Elhadad S; Copertino D; Laurence J
AIDS Patient Care STDS; 2016 Aug; 30(8):359-64. PubMed ID: 27509235
[TBL] [Abstract][Full Text] [Related]
30. Thrombotic microangiopathies.
Rosove MH
Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
Fakhouri F
Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia.
Csuka D; Molvarec A; Derzsy Z; Varga L; Füst G; Rigó J; Prohászka Z
J Reprod Immunol; 2010 Dec; 87(1-2):90-6. PubMed ID: 20952075
[TBL] [Abstract][Full Text] [Related]
33. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
Gavriilaki E; Anagnostopoulos A; Mastellos DC
Front Immunol; 2019; 10():337. PubMed ID: 30891033
[TBL] [Abstract][Full Text] [Related]
34. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
[TBL] [Abstract][Full Text] [Related]
35. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
Gavriilaki E; Ho VT; Schwaeble W; Dudler T; Daha M; Fujita T; Jodele S
Exp Hematol Oncol; 2021 Dec; 10(1):57. PubMed ID: 34924021
[TBL] [Abstract][Full Text] [Related]
36. Transplant-associated thrombotic microangiopathy: opening Pandora's box.
Gavriilaki E; Sakellari I; Anagnostopoulos A; Brodsky RA
Bone Marrow Transplant; 2017 Oct; 52(10):1355-1360. PubMed ID: 28287636
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
38. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
Zhang B; Xing G
Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
[TBL] [Abstract][Full Text] [Related]
39. Activation of the lectin pathway of complement in pig-to-human xenotransplantation models.
Bongoni AK; Kiermeir D; Jenni H; Wünsch A; Bähr A; Ayares D; Seebach JD; Wolf E; Klymiuk N; Constantinescu MA; Vögelin E; Rieben R
Transplantation; 2013 Nov; 96(9):791-9. PubMed ID: 23958924
[TBL] [Abstract][Full Text] [Related]
40. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
